Logo 661 (Ropinirole Hydrochloride Extended-Release 12 mg)
Pill with imprint Logo 661 is Yellow, Elliptical / Oval and has been identified as Ropinirole Hydrochloride Extended-Release 12 mg. It is supplied by Actavis Elizabeth LLC.
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 12 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 661
Ropinirole Hydrochloride Extended-Release
- Imprint:
- Logo 661
- Strength:
- 12 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Elizabeth LLC
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
castor oil
hypromelloses
lactose monohydrate
magnesium stearate
maltodextrin
titanium dioxide
ferric oxide yellow
polyethylene glycol
polyvinyl alcohol
magnesium silicate
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 42291-0717 | AvKare, Inc. |
More about ropinirole
- Ropinirole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 241 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Consumer resources
Other brands: Requip, Requip XL
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
